Immuno-Biological Laboratories Co., Ltd. (4570.T)

JPY 452.0

(1.8%)

Operating Expenses Summary of Immuno-Biological Laboratories Co., Ltd.

  • Immuno-Biological Laboratories Co., Ltd.'s latest annual operating expenses in 2023 was 412.99 Million JPY , down -11.82% from previous year.
  • Immuno-Biological Laboratories Co., Ltd.'s latest quarterly operating expenses in 2024 Q1 was 98 Million JPY , up 5.92% from previous quarter.
  • Immuno-Biological Laboratories Co., Ltd. reported a annual operating expenses of 468.33 Million JPY in annual operating expenses 2022, down -6.13% from previous year.
  • Immuno-Biological Laboratories Co., Ltd. reported a annual operating expenses of 498.91 Million JPY in annual operating expenses 2021, down -15.13% from previous year.
  • Immuno-Biological Laboratories Co., Ltd. reported a quarterly operating expenses of 115.13 Million JPY for 2023 Q3, up 16.98% from previous quarter.
  • Immuno-Biological Laboratories Co., Ltd. reported a quarterly operating expenses of 102.22 Million JPY for 2023 Q1, down -16.96% from previous quarter.

Annual Operating Expenses Chart of Immuno-Biological Laboratories Co., Ltd. (2023 - 2019)

Historical Annual Operating Expenses of Immuno-Biological Laboratories Co., Ltd. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 412.99 Million JPY -11.82%
2022 468.33 Million JPY -6.13%
2021 498.91 Million JPY -15.13%
2020 587.83 Million JPY -32.82%
2019 875 Million JPY 0.0%

Peer Operating Expenses Comparison of Immuno-Biological Laboratories Co., Ltd.

Name Operating Expenses Operating Expenses Difference
KOHJIN BIO CO LTD 1.28 Billion JPY 67.848%
PRISM BioLab Co.,LTD 576.81 Million JPY 28.402%
GNI Group Ltd. 9.32 Billion JPY 95.57%
Linical Co., Ltd. 2.7 Billion JPY 84.733%
Trans Genic Inc. 2.15 Billion JPY 80.879%
MEDINET Co., Ltd. 1.49 Billion JPY 72.304%
Soiken Holdings Inc. 3.07 Billion JPY 86.552%
Cytori Cell Research Institute, Inc. 1.85 Billion JPY 77.76%
AnGes, Inc. 8.9 Billion JPY 95.361%
OncoTherapy Science, Inc. 943.08 Million JPY 56.208%
Nxera Pharma Co., Ltd. 19.19 Billion JPY 97.848%
NanoCarrier Co., Ltd. 975.37 Million JPY 57.658%
Carna Biosciences, Inc. 2.56 Billion JPY 83.915%
CanBas Co., Ltd. 278 Million JPY -48.558%
D. Western Therapeutics Institute, Inc. 1.14 Billion JPY 63.822%
RaQualia Pharma Inc. 1.81 Billion JPY 77.283%
Chiome Bioscience Inc. 1.6 Billion JPY 74.249%
Kidswell Bio Corporation 2.37 Billion JPY 82.604%
PeptiDream Inc. 9.68 Billion JPY 95.737%
Oncolys BioPharma Inc. 1.96 Billion JPY 78.935%
Ribomic Inc. 1.1 Billion JPY 62.649%
SanBio Company Limited 4.53 Billion JPY 90.901%
Healios K.K. 3.48 Billion JPY 88.156%
BrightPath Biotherapeutics Co., Ltd. 1.15 Billion JPY 64.235%
Kubota Pharmaceutical Holdings Co., Ltd. 1.33 Billion JPY 69.052%
Delta-Fly Pharma, Inc. 1.4 Billion JPY 70.574%
StemRIM 2.07 Billion JPY 80.106%
CellSource Co., Ltd. 1.96 Billion JPY 78.967%
FunPep Company Limited 313.82 Million JPY -31.6%
Kringle Pharma, Inc. 958.01 Million JPY 56.891%
Stella Pharma Corporation 963.98 Million JPY 57.158%
TMS Co., Ltd. 943.25 Million JPY 56.216%
Noile-Immune Biotech Inc. 1.08 Billion JPY 62.109%
Cuorips Inc. 598.11 Million JPY 30.952%
K Pharma,Inc. 543.94 Million JPY 24.075%
Takara Bio Inc. 23.9 Billion JPY 98.272%
ReproCELL Incorporated 1.51 Billion JPY 72.722%
PhoenixBio Co., Ltd. 1.18 Billion JPY 65.119%
StemCell Institute Inc. 1.16 Billion JPY 64.462%
Japan Tissue Engineering Co., Ltd. 1.52 Billion JPY 72.87%
CellSeed Inc. 804.93 Million JPY 48.692%